Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Mol Cell Proteomics ; 11(12): 1690-708, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22956732

ABSTRACT

In Swiss 3T3 fibroblasts, long-term stimulation with PDGF, but not insulin-like growth factor 1 (IGF-1) or EGF, results in the establishment of an elongated migratory phenotype, characterized by the formation of retractile dendritic protrusions and absence of actin stress fibers and focal adhesion complexes. To identify receptor tyrosine kinase-specific reorganization of the Swiss 3T3 proteome during phenotypic differentiation, we compared changes in the pattern of protein synthesis and phosphorylation during long-term exposure to PDGF, IGF-1, EGF, and their combinations using 2DE-based proteomics after (35)S- and (33)P-metabolic labeling. One hundred and five differentially regulated proteins were identified by mass spectrometry and some of these extensively validated. PDGF stimulation produced the highest overall rate of protein synthesis at any given time and induced the most sustained phospho-signaling. Simultaneous activation with two or three of the growth factors revealed both synergistic and antagonistic effects on protein synthesis and expression levels with PDGF showing dominance over both IGF-1 and EGF in generating distinct proteome compositions. Using signaling pathway inhibitors, PI3K was identified as an early site for signal diversification, with sustained activity of the PI3K/AKT pathway critical for regulating late protein synthesis and phosphorylation of target proteins and required for maintaining the PDGF-dependent motile phenotype. Several proteins were identified with novel PI3K/Akt-dependent synthesis and phosphorylations including eEF2, PRS7, RACK-1, acidic calponin, NAP1L1, Hsp73, and fascin. The data also reveal induction/suppression of key F-actin and actomyosin regulators and chaperonins that enable PDGFR to direct the assembly of a motile cytoskeleton, despite simultaneous antagonistic signaling activities. Together, the study demonstrates that long-term exposure to different growth factors results in receptor tyrosine kinase-specific regulation of relatively small subproteomes, and implies that the strength and longevity of receptor tyrosine kinase-specific signals are critical in defining the composition and functional activity of the resulting proteome.


Subject(s)
Epidermal Growth Factor/pharmacology , Insulin-Like Growth Factor I/pharmacology , Phosphatidylinositol 3-Kinases/metabolism , Platelet-Derived Growth Factor/pharmacology , Proteome/analysis , 3T3 Cells , Animals , Benzamides/pharmacology , Calcium-Calmodulin-Dependent Protein Kinases/antagonists & inhibitors , Cell Line , Chromones/pharmacology , Enzyme Inhibitors/pharmacology , Fibroblasts , Flavonoids/pharmacology , Isotope Labeling , Mice , Morpholines/pharmacology , Nucleosome Assembly Protein 1/metabolism , Phosphoinositide-3 Kinase Inhibitors , Phosphorylation/drug effects , Proto-Oncogene Proteins c-akt/metabolism , Receptor Protein-Tyrosine Kinases/metabolism , Receptors, Platelet-Derived Growth Factor/metabolism , Signal Transduction/drug effects
2.
J Proteomics ; 74(10): 1985-93, 2011 Sep 06.
Article in English | MEDLINE | ID: mdl-21621025

ABSTRACT

We performed here MS-based cell surface proteome profiling of HCT-116 cells by two distinct methods based on biotin labeling and glycoprotein capturing. In total, 742 biotinylated and 219 glycosylated proteins were identified by the biotin labeling and glycoprotein capturing, of which 224 and 138 proteins known to be located on plasma membrane were included, respectively, according to ingenuity pathway analysis. Although 104 plasma membrane proteins were identified by both methods, the rest of 154 were identified only by one. Almost all the identified plasma membrane proteins possessed consensus N-glycosylation sites, and proteins having various numbers of glycosylation sites were identified by both methods. Thus, the discrepancies of the identified proteins obtained from those two methods might not be only due to the number of glycosylation sites, but also to the expression and/or glycosylation level of the cell surface proteins. We also identified 312 N-glycosylated proteins from xenograft samples by glycoprotein capturing of which 135 were known as plasma membrane proteins. Although a number of highly-expressed plasma membrane proteins were common between culture and xenograft cells, some proteins showed culture- or xenograft-specific expression, suggesting that those proteins might contribute to grow in different environment.


Subject(s)
Biotinylation/methods , Membrane Proteins/analysis , Proteomics/methods , Animals , Chromatography, Liquid , Glycoproteins/metabolism , Glycosylation , HCT116 Cells , Humans , Mice , Tandem Mass Spectrometry , Transplantation, Heterologous
3.
Expert Rev Proteomics ; 8(1): 81-94, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21329429

ABSTRACT

Protein phosphorylation is a central regulatory mechanism of cell signaling pathways. This highly controlled biochemical process is involved in most cellular functions, and defects in protein kinases and phosphatases have been implicated in many diseases, highlighting the importance of understanding phosphorylation-mediated signaling networks. However, phosphorylation is a transient modification, and phosphorylated proteins are often less abundant. Therefore, the large-scale identification and quantification of phosphoproteins and their phosphorylation sites under different conditions are one of the most interesting and challenging tasks in the field of proteomics. Both 2D gel electrophoresis and liquid chromatography-tandem mass spectrometry serve as key phosphoproteomic technologies in combination with prefractionation, such as enrichment of phosphorylated proteins/peptides. Recently, new possibilities for quantitative phosphoproteomic analysis have been offered by technical advances in sample preparation, enrichment, separation, instrumentation, quantification and informatics. In this article, we present an overview of several strategies for quantitative phosphoproteomics and discuss how phosphoproteomic analysis can help to elucidate signaling pathways that regulate various cellular processes.


Subject(s)
Phosphoproteins/analysis , Protein Kinases/metabolism , Proteomics/methods , Animals , Electrophoresis, Gel, Two-Dimensional , Evaluation Studies as Topic , Gene Expression Profiling , Humans , Mice , Protein Kinases/genetics , Signal Transduction , Tandem Mass Spectrometry/methods
4.
J Proteomics ; 74(3): 319-26, 2011 Mar 01.
Article in English | MEDLINE | ID: mdl-21118733

ABSTRACT

We performed here MS-based phosphoproteomics using both metal oxide affinity chromatography (pSTY proteomics) and anti-phosphotyrosine antibody (pY proteomics). The former method identified mainly phospho-serine and -threonine of nuclear or cytoplasmic proteins, whereas the latter did phosphotyrosine including more plasma membrane proteins and kinases. The overlap between these two methods was limited (24 tyrosine phosphorylation sites out of 325) and, by combining the two, coverage of the signaling molecules was enhanced as exemplified by Erk signaling. We also performed whole cell proteomics using an off-gel fractionator, and found 68.9% of the proteins identified by phosphoproteomics. Thus, the expression levels of phosphoproteins were roughly estimated. In addition to many uncharacterized phosphorylation sites, the dataset includes 136 sites that were experimentally verified elsewhere to be phosphorylated by a total of 83 kinases and kinase groups out of the 256 registered in the Phospho.ELM database. With the integration of various proteomic analyses and information from database, the responsible kinases of the identified phosphorylation sites and possibly their activity status were predicted by phosphorylation status and expression levels of their substrates, and thus our method may be able to monitor the activity status of phosphorylation signaling.


Subject(s)
Proteomics/methods , Binding Sites , Cell Line, Tumor , Cell Membrane/metabolism , Databases, Protein , Humans , Mass Spectrometry/methods , Metals/chemistry , Oxides/chemistry , Phosphorylation , Phosphotyrosine/chemistry , Proteome , Signal Transduction , Trypsin/chemistry , Tyrosine/chemistry
5.
J Proteomics ; 73(2): 357-60, 2009 Dec 01.
Article in English | MEDLINE | ID: mdl-19733703

ABSTRACT

We developed a software program (titled Precursor Ion Calibration software for LTQ or, in short, PICsL) that increases the reliability of precursor ion assignations from LC-MS analysis using ultra zoom scanning of LTQ linear ion trap MS and automatically corrects the assignations. Although existing software calculates the theoretical isotopic distribution according to m/z with a computational algorithm, our method simply searches for ions close to the theoretical mass value using both MS/MS raw data and Mascot search result files, followed by a second database search that identifies the proteins using the regenerated peak list files. Our software program mimics the manual inspection of the spectral data of precursor ions and is expected to be applicable not only for low resolution MS, such as LTQ, but also for a wide variety of MS instruments.


Subject(s)
Ions/analysis , Mass Spectrometry/methods , Software , Algorithms , Chromatography, Liquid , Isotopes/analysis
6.
Proteomics ; 9(10): 2861-74, 2009 May.
Article in English | MEDLINE | ID: mdl-19415658

ABSTRACT

Here, we report for the first time a comparative phosphoproteomic analysis of distinct tumor cell lines in the presence or absence of the microtubule-interfering agent nocodazole. In total, 1525 phosphorylation sites assigned to 726 phosphoproteins were identified using LC-MS-based technology following phosphopeptide enrichment. Analysis of the amino acid composition surrounding the identified in vivo phosphorylation sites revealed that they could be classified into two motif groups: pSer-Pro and pSer-Asp/Glu. Phosphoproteomic change resulting from nocodazole treatment varied among cell lines in terms of the numbers of total phosphopeptides identified, motif groups, and functional annotation groups; however, the cell lines were equally sensitive to nocodazole. The identified phosphoproteome subset contained major signaling proteins and proteins known to be involved in mitosis, but did not always exhibit the same changes in the tumor cells from nocodazole treatment. In spite of the complex changes observed in the phosphorylation of many of the proteins, possible common features induced by nocodazole were found, including phosphorylation of nucleophosmin (NPM) S254 and coatomer protein complex, subunit alpha (COPA) S173, suggesting that the events are not cell-type specific but events generally occurring in mitosis or induced by a microtubule-interfering agent. Further, temporal analysis of phosphoproteome change revealed that phosphorylation of NPM S254 and COPA S173 was observed from the early (6 h) and late (24 h) time point after nocodazole treatment, respectively, suggesting that NPM S254 may be involved in the induction of M-phase arrest by nocodazole, whereas COPA S173 may be caused as a result of M-phase arrest.


Subject(s)
Gene Expression Regulation, Neoplastic/drug effects , Neoplasm Proteins/analysis , Nocodazole/pharmacology , Phosphoproteins/analysis , Amino Acid Sequence , Cell Line, Tumor , Chromatography, Liquid , HCT116 Cells , HeLa Cells , Humans , Mass Spectrometry , Mitosis , Molecular Sequence Data , Neoplasm Proteins/genetics , Neoplasm Proteins/metabolism , Phosphoproteins/metabolism , Phosphorylation , Protein Structure, Tertiary , Proteomics , Signal Transduction , Time Factors
7.
Proteomics ; 8(19): 4025-35, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18763704

ABSTRACT

Embryonic stem cells (ESCs) can give rise to any adult cell type and thus offer enormous potential for regenerative medicine and drug discovery. Molecular biomarkers serve as valuable tools to classify and isolate ESCs and to monitor their differentiation state by antibody-based techniques. A number of biomarkers, such as certain cell surface antigens, are used to assign pluripotent ESCs; however, accumulating evidence suggests that ESCs are heterogeneous in morphology, phenotype and function, and are thereby classified into subpopulations characterized by multiple sets of molecular biomarkers. Biomarker discovery is also important for ESC biology to elucidate the molecular mechanisms that regulate pluripotency and differentiation. This review summarizes studies of ESC biomarker discovery. "Genome-wide" expression profiling of ESC mRNAs and proteins and direct analyses of the cell surface subproteome have demonstrated that ESCs express a diverse range of biomarkers, cell surface antigens, and signaling molecules found in different cell lineages, as well as a number of key molecules that assure "stemness". Clearly, future quantitative proteomics approaches will enhance our knowledge of the stage- and lineage-specific expression of the proteome and its temporal changes upon differentiation, and provide a more detailed view of nascent and clonally amplified ESCs.


Subject(s)
Biomarkers/analysis , Embryonic Stem Cells/metabolism , Membrane Proteins/analysis , Proteomics/methods , Animals , Embryonic Stem Cells/cytology , Genomics/methods , Humans , Membrane Proteins/genetics , Models, Biological
8.
EMBO J ; 25(9): 1871-82, 2006 May 03.
Article in English | MEDLINE | ID: mdl-16619033

ABSTRACT

PDGF is a potent chemotactic mitogen and a strong inductor of fibroblast motility. In Swiss 3T3 fibroblasts, exposure to PDGF but not EGF or IGF-1 causes a rapid loss of actin stress fibers (SFs) and focal adhesions (FAs), which is followed by the development of retractile dendritic protrusions and induction of motility. The PDGF-specific actin reorganization was blocked by inhibition of Src-kinase and the 26S proteasome. PDGF induced Src-dependent association between the multifunctional transcription/translation regulator hnRNP-K and the mRNA-encoding myosin regulatory light-chain (MRLC)-interacting protein (MIR), a E(3)-ubiquitin ligase that is MRLC specific. This in turn rapidly increased MIR expression, and led to ubiquitination and proteasome-mediated degradation of MRLC. Downregulation of MIR by RNA muting prevented the reorganization of actin structures and severely reduced the migratory and wound-healing potential of PDGF-treated cells. The results show that activation of MIR and the resulting removal of diphosphorylated MRLC are essential for PDGF to instigate and maintain control over the actin-myosin-based contractile system in Swiss 3T3 fibroblasts. The PDGF induced protein destabilization through the regulation of hnRNP-K controlled ubiquitin -ligase translation identifies a novel pathway by which external stimuli can regulate phenotypic development through rapid, organelle-specific changes in the activity and stability of cytoskeletal regulators.


Subject(s)
Actins/drug effects , Cytoskeleton/drug effects , Heterogeneous-Nuclear Ribonucleoprotein K/metabolism , Platelet-Derived Growth Factor/pharmacology , Ubiquitin-Protein Ligases/metabolism , Actin Cytoskeleton/drug effects , Actin Cytoskeleton/metabolism , Actins/metabolism , Animals , Cell Movement , Cytoskeleton/metabolism , Cytoskeleton/ultrastructure , Down-Regulation , Enzyme Activation , Epidermal Growth Factor/pharmacology , Fibroblasts/drug effects , Fibroblasts/physiology , Fibroblasts/ultrastructure , Insulin-Like Growth Factor I/pharmacology , Mice , Myosin Light Chains/metabolism , Proteasome Endopeptidase Complex , Proteasome Inhibitors , RNA, Small Interfering/genetics , RNA, Small Interfering/pharmacology , Swiss 3T3 Cells , Ubiquitin-Protein Ligases/antagonists & inhibitors , Ubiquitin-Protein Ligases/genetics , src-Family Kinases/antagonists & inhibitors
9.
Mol Cell Proteomics ; 4(12): 1968-76, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16176923

ABSTRACT

Although interactions between cell surface proteins and extracellular ligands are key to initiating embryonic stem cell differentiation to specific cell lineages, the plasma membrane protein components of these cells are largely unknown. We describe here a group of proteins expressed on the surface of the undifferentiated mouse embryonic stem cell line D3. These proteins were identified using a combination of cell surface labeling with biotin, subcellular fractionation of plasma membranes, and mass spectrometry-based protein identification technology. From 965 unique peptides carrying biotin labels, we assigned 324 proteins including 235 proteins that have putative signal sequences and/or transmembrane segments. Receptors, transporters, and cell adhesion molecules were the major classes of proteins identified. Besides known cell surface markers of embryonic stem cells, such as alkaline phosphatase, the analysis identified 59 clusters of differentiation-related molecules and more than 80 components of multiple cell signaling pathways that are characteristic of a number of different cell lineages. We identified receptors for leukemia-inhibitory factor, interleukin 6, and bone morphogenetic protein, which play critical roles in the maintenance of undifferentiated mouse embryonic stem cells. We also identified receptors for growth factors/cytokines, such as fibroblast growth factor, platelet-derived growth factor, ephrin, Hedgehog, and Wnt, which transduce signals for cell differentiation and embryonic development. Finally we identified a variety of integrins, cell adhesion molecules, and matrix metalloproteases. These results suggest that D3 cells express diverse cell surface proteins that function to maintain pluripotency, enabling cells to respond to various external signals that initiate differentiation into a variety of cell types.


Subject(s)
Cell Membrane/ultrastructure , Membrane Proteins/chemistry , Stem Cells/ultrastructure , Amino Acid Sequence , Animals , Automation , Base Sequence , Biomarkers/analysis , Biotinylation , Cell Fractionation , Cell Line , DNA Primers , Embryo, Mammalian , Mass Spectrometry/methods , Membrane Proteins/genetics , Mice , Peptide Fragments/chemistry , Signal Transduction , Stem Cells/physiology
10.
Proteomics ; 5(5): 1346-61, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15742316

ABSTRACT

A protein subset expressed in the mouse embryonic stem (ES) cell line, E14-1, was characterized by mass spectrometry-based protein identification technology and data analysis. In total, 1790 proteins including 365 potential nuclear and 260 membrane proteins were identified from tryptic digests of total cell lysates. The subset contained a variety of proteins in terms of physicochemical characteristics, subcellular localization, and biological function as defined by Gene Ontology annotation groups. In addition to many housekeeping proteins found in common with other cell types, the subset contained a group of regulatory proteins that may determine unique ES cell functions. We identified 39 transcription factors including Oct-3/4, Sox-2, and undifferentiated embryonic cell transcription factor I, which are characteristic of ES cells, 88 plasma membrane proteins including cell surface markers such as CD9 and CD81, 44 potential proteinaceous ligands for cell surface receptors including growth factors, cytokines, and hormones, and 100 cell signaling molecules. The subset also contained the products of 60 ES-specific and 41 stemness genes defined previously by the DNA microarray analysis of Ramalho-Santos et al. (Ramalho-Santos et al., Science 2002, 298, 597-600), as well as a number of components characteristic of differentiated cell types such as hematopoietic and neural cells. We also identified potential post-translational modifications in a number of ES cell proteins including five Lys acetylation sites and a single phosphorylation site. To our knowledge, this study provides the largest proteomic dataset characterized to date for a single mammalian cell species, and serves as a basic catalogue of a major proteomic subset that is expressed in mouse ES cells.


Subject(s)
Proteome/analysis , Stem Cells/physiology , Animals , Cell Line , Embryo, Mammalian , Gene Expression Regulation , Humans , Mass Spectrometry , Mice , Molecular Sequence Data , Protein Array Analysis , Protein Processing, Post-Translational , Stem Cells/cytology , Transcription Factors/analysis
11.
Oncogene ; 23(9): 1693-703, 2004 Mar 04.
Article in English | MEDLINE | ID: mdl-14647428

ABSTRACT

Protein expression and de novo synthesis in normal and prostate cancer cell lines derived from the same patient were compared by proteomic analysis, and the effects of INFalpha and INFgamma (INF=interferon) determined. The expressions of several INF-inducible proteins, including MxA, Nmi, PA28a and IFP53, were downregulated in the cancer cells. INFgamma induced a more than twofold increase or decrease in the synthesis rates of almost twice as many proteins in the cancer cell line. The positive regulator of INF-induced transcription ISGF3gamma was upregulated in the cancer cells and inversely regulated by INFalpha and INFgamma in the normal and cancer cells. Moreover, ISGF3gamma's induction by INFgamma in the cancer cells was more enhanced by simultaneous stimulation with EGF, than its induction in the normal cells. In all, 31 differentially regulated proteins were identified by mass spectrometry analysis, several of which are involved in chaperone-assisted protein folding in the endoplasmic reticulum (ER) or in regulated protein degradation. Our results suggest that the exclusion of proteins by the ER quality control system, crosstalk between the EGF- and INF-induced signalling pathways and the regulation of INF-inducible genes are all altered in the prostate cancer cells. The combination of upregulated activity in the growth-promoting PI3K/Akt pathway, suppression of Nmi and overexpression of hnRNP-K and c-myc proteins may explain why the prostate cancer cells were found to be more resistant to the growth inhibitory effects of INFgamma.


Subject(s)
Gene Expression Profiling , Gene Expression Regulation, Neoplastic/drug effects , Interferon-alpha/pharmacology , Interferon-gamma/pharmacology , Intracellular Signaling Peptides and Proteins , Prostate/metabolism , Prostatic Neoplasms/metabolism , Proteome/biosynthesis , Carrier Proteins/metabolism , Cell Division/drug effects , Cell Line , Cell Line, Tumor , DNA-Binding Proteins/biosynthesis , Electrophoresis, Gel, Two-Dimensional , Epidermal Growth Factor/pharmacology , GTP-Binding Proteins/biosynthesis , Heterogeneous-Nuclear Ribonucleoprotein K/biosynthesis , Humans , Interferon-Stimulated Gene Factor 3 , Interferon-Stimulated Gene Factor 3, gamma Subunit , Male , Mitogen-Activated Protein Kinases/metabolism , Myxovirus Resistance Proteins , Phosphatidylinositol 3-Kinases/metabolism , Phosphorylation/drug effects , Prostate/cytology , Prostate/pathology , Prostatic Neoplasms/enzymology , Prostatic Neoplasms/pathology , Signal Transduction/drug effects , Spectrometry, Mass, Electrospray Ionization , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Transcription Factors/biosynthesis
SELECTION OF CITATIONS
SEARCH DETAIL
...